Clot-busting drug after stroke in people on newer blood thinners
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You had a stroke that started within the last 24 hours (or you woke up with stroke symptoms that likely started within 24 hours).
- You took a new oral blood thinner (like apixaban, rivaroxaban, or edoxaban) within 4 to 48 hours before your stroke symptoms began.
- You are not planning to have a clot-removal procedure (endovascular treatment).
- You do not have any conditions that make it unsafe to receive clot-busting medication, such as active bleeding, recent surgery, high blood pressure, or low blood platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a clot-busting medicine given through a vein can help people who have had a stroke in the last 3 months and are now having another stroke. The goal is to see if this treatment is safe and improves recovery.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
This trial tests whether a stronger clot-busting drug (tenecteplase) is safe and works for people who have had a stroke while taking a common blood thinner. If you qualify, you may get this treatment within a few hours of your stroke to help improve recovery.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.